Jason A Zell
Overview
Explore the profile of Jason A Zell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
1949
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Dasari A, Morris V, Allegra C, Atreya C, Benson 3rd A, Boland P, et al.
Nat Rev Clin Oncol
. 2020 Jul;
17(12):757-770.
PMID: 32632268
An increasing number of studies are describing potential uses of circulating tumour DNA (ctDNA) in the care of patients with colorectal cancer. Owing to this rapidly developing area of research,...
22.
Zell J, McLaren C, Morgan T, Lawson M, Rezk S, Albers C, et al.
Cancer Prev Res (Phila)
. 2019 Dec;
13(2):203-212.
PMID: 31818851
Obesity is associated with risk of colorectal adenoma (CRA) and colorectal cancer. The signaling pathway activated by metformin (LKB1/AMPK/mTOR) is implicated in tumor suppression in Apc mice via metformin-induced reduction...
23.
Gahagan J, Whealon M, Phelan M, Mills S, Jafari M, Carmichael J, et al.
Surg Oncol
. 2019 Nov;
32:35-40.
PMID: 31726418
Objective: The aim of this study is to examine the effect of postoperative chemotherapy on survival in patients with stage II or III rectal adenocarcinoma who undergo neoadjuvant chemoradiation (CRT)...
24.
Ou C, Vu T, Grunwald J, Toledano M, Zimak J, Toosky M, et al.
Lab Chip
. 2019 Feb;
19(6):993-1005.
PMID: 30735225
Current cancer detection systems lack the required sensitivity to reliably detect minimal residual disease (MRD) and recurrence at the earliest stages when treatment would be most effective. To address this...
25.
Tran P, Taylor T, Klempner S, Zell J
J Carcinog
. 2017 Oct;
16:3.
PMID: 28974922
Background: African Americans and Hispanics are reported to have higher mortality from esophageal cancer (EC) than Caucasians. In this study, we analyzed the independent effects of race, gender, treatment, and...
26.
Moghadamyeghaneh Z, Fazl Alizadeh R, Phelan M, Carmichael J, Mills S, Pigazzi A, et al.
Surg Endosc
. 2015 Nov;
30(8):3604-10.
PMID: 26541735
Background: Colorectal cancer (CRC) incidence is rising among patients under age 50. As such, we set out to determine the proportion of CRC-related hospital admissions and distribution of colon cancer...
27.
Zhang K, Kang D, Ali M, Liu L, Labanieh L, Lu M, et al.
Lab Chip
. 2015 Sep;
15(21):4217-26.
PMID: 26387763
Quantification of miRNAs in blood can be potentially used for early disease detection, surveillance monitoring and drug response evaluation. However, quantitative and robust measurement of miRNAs in blood is still...
28.
Gillen D, Meyskens F, Morgan T, Zell J, Carroll R, Benya R, et al.
Cancer Prev Res (Phila)
. 2015 Jan;
8(3):222-30.
PMID: 25604134
Colorectal cancer progresses through multiple distinct stages that are potentially amenable to chemopreventative intervention. Epidermal growth factor receptor (EGFR) inhibitors are efficacious in advanced tumors including colorectal cancer. There is...
29.
Singh K, Taylor T, Pan C, Stamos M, Zell J
J Adolesc Young Adult Oncol
. 2014 Dec;
3(4):176-184.
PMID: 25538862
Colorectal cancer (CRC) incidence has decreased over the past three decades, due largely to screening efforts. Relatively little is known about CRC incidence among the young adult (YA) population ages...
30.
Tsang W, Ziogas A, Lin B, Seery T, Karnes W, Stamos M, et al.
J Gastrointest Surg
. 2013 Dec;
18(3):592-8.
PMID: 24297651
Introduction: The benefit of an operation to remove the primary tumor among patients with synchronous stage IV colorectal cancer is controversial. This study analyzed the survival benefits associated with primary...